Chemoinformaics analysis of Benzene, (2-methoxy-1-propenyl)-
| Molecular Weight | 148.205 | nRot | 2 |
| Heavy Atom Molecular Weight | 136.109 | nRig | 7 |
| Exact Molecular Weight | 148.089 | nRing | 1 |
| Solubility: LogS | -2.678 | nHRing | 0 |
| Solubility: LogP | 2.911 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 1 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 23 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 11 | No. of Aromatic Carbocycles | 1 |
| nHetero | 1 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 12 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 10 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 6 |
| No. of Oxygen atom | 1 | No. of Arom Bond | 6 |
| nHA | 1 | APOL | 25.5035 |
| nHD | 0 | BPOL | 13.7745 |
| QED | 0.586 |
| Synth | 1.988 |
| Natural Product Likeliness | 0.113 |
| NR-PPAR-gamma | 0.002 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Rejected |
| Pgp-inh | 0.006 |
| Pgp-sub | 0.238 |
| HIA | 0.007 |
| CACO-2 | -4.308 |
| MDCK | 0.0000248 |
| BBB | 0.979 |
| PPB | 0.884745 |
| VDSS | 3.716 |
| FU | 0.106049 |
| CYP1A2-inh | 0.971 |
| CYP1A2-sub | 0.885 |
| CYP2c19-inh | 0.577 |
| CYP2c19-sub | 0.768 |
| CYP2c9-inh | 0.171 |
| CYP2c9-sub | 0.527 |
| CYP2d6-inh | 0.055 |
| CYP2d6-sub | 0.453 |
| CYP3a4-inh | 0.041 |
| CYP3a4-sub | 0.464 |
| CL | 10.227 |
| T12 | 0.768 |
| hERG | 0.053 |
| Ames | 0.021 |
| ROA | 0.014 |
| SkinSen | 0.955 |
| Carcinogencity | 0.364 |
| EI | 0.992 |
| Respiratory | 0.068 |
| NR-Aromatase | 0.006 |
| Antiviral | No |
| Prediction | 0.902244 |